Dashboard

Danaher Corp. (DHR)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

B

Analyst Opinion

H

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

About

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

CEO

Thomas Patrick Joyce

Employees

60,000

Industry

Diversified Medical Devices and Instruments

Sector

Healthcare

Headquarters

Washington

Exchange

New York Stock Exchange

Summary Stats

Market Cap

180B

Revenue

31.5B

Net Income

7.1B

EPS

$9.64

Price-to-Earnings

25.61

Price-to-Book

3.59

Debt-to-Equity

0.68

News

Analyst Ratings

Price targets projected by 17 analysts

High

$280.00

Average

$261.35

Low

$234.00

Ratings calculated by 20 analysts

Buy

17

Hold

2

Sell

1

Last Dividend

Amount

$0.25

Dividend Date

Frequency

quarterly

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q4 2022

Last Earnings

Above by $0.36

Actual

$2.87 +14.3%

Consensus

2.51

Report Date

Year Ago

2.69

Year Ago Change %

Up 6%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites